Mr. Iwanicki discusses the significance of the Federal Circuit rehearing the Ariad Pharmaceuticals v. Eli Lilly case and who should be watching this case, in an IP Law 360 article titled: Fed. Circ. To Weigh In On Written Description Rule.
Posted: October 8, 2009
